RxDoctor Payments Data

Brittany Howard, MD

Otolaryngology · Scottsdale, AZNPI 1235458001

Payments from drug & device makers

What this record shows

7 manufacturers reported payments, led by Synthes GmbH at 44.4% of the total. Reporting peaked in 2021 at $500 and has fallen 59.0% since, to $205 in 2025. That places this record below the midpoint for otolaryngology clinicians in AZ, where the typical reported total is $1,230.

$1,127in general payments, 2019–2025

Across 9 payments — averaging $125.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Synthes GmbH$500
  • Medtronic$295
  • AbbVie$209
  • Galderma Research & Development, LLC$61
  • Cook Medical LLC$27
  • Calliditas Therapeutics US Inc.$19
  • plus $17 from 1 others
$78,725in research payments, 2019–2025

Across 23 payments — averaging $3422.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Galderma Laboratories, L.p.$50K
  • AbbVie$28K

What the payments were for

  • Speaking & faculty fees$50044%
  • Food & beverage$62756%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,127 in reported general payments places this provider in the 45th percentile of 150 otolaryngology providers in Arizona.

See all otolaryngology providers in Arizona

Medicare billing

Part B allowed, 2024
$99,419
Medicare patients
100
Services billed
3,314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pentoxifylline14$711
Doxycycline Monohydrate12$638
Ipratropium Bromide13$332

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →